Incyte
INCY
#977
Rank
C$34.09 B
Marketcap
C$168.22
Share price
3.07%
Change (1 day)
28.45%
Change (1 year)

EPS for Incyte (INCY)

EPS in 2026 (TTM): C$11.36

According to Incyte's latest financial reports the company's current EPS (TTM) is C$11.36. In 2025 the company made an earnings per share (EPS) of C$9.22 an increase over its 2024 EPS that were of C$0.43.

EPS history for Incyte from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$11.3623.23%
2025C$9.222029.03%
2024C$0.43-88.39%
2023C$3.7373.38%
2022C$2.15-64.1%
2021C$5.99-408.63%
2020C-$1.94-166.83%
2019C$2.91300%
2018C$0.73-133.33%
2017C-$2.18-378.57%
2016C$0.782700%
2015C$0.02795-106.67%
2014C-$0.42-44.44%
2013C-$0.7550%
2012C-$0.50

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
C$9.31-18.08%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$1.06-90.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$41.76 267.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$22.66 99.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
C$13.99 23.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
C-$0.15-101.35%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
C-$0.81-107.13%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
C-$1.17-110.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
C-$0.31-102.71%๐Ÿ‡บ๐Ÿ‡ธ USA